BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12125807)

  • 1. Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease.
    Motyckova G; Fisher DE
    Curr Mol Med; 2002 Aug; 2(5):407-21. PubMed ID: 12125807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.
    Gelb BD; Shi GP; Chapman HA; Desnick RJ
    Science; 1996 Aug; 273(5279):1236-8. PubMed ID: 8703060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice.
    Saftig P; Hunziker E; Wehmeyer O; Jones S; Boyde A; Rommerskirch W; Moritz JD; Schu P; von Figura K
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13453-8. PubMed ID: 9811821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice.
    Saftig P; Hunziker E; Everts V; Jones S; Boyde A; Wehmeyer O; Suter A; von Figura K
    Adv Exp Med Biol; 2000; 477():293-303. PubMed ID: 10849757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erosive arthritis in a patient with pycnodysostosis: an experiment of nature.
    Ainola M; Valleala H; Nykänen P; Risteli J; Hanemaaijer R; Konttinen YT
    Arthritis Rheum; 2008 Nov; 58(11):3394-401. PubMed ID: 18975331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.
    Chen W; Yang S; Abe Y; Li M; Wang Y; Shao J; Li E; Li YP
    Hum Mol Genet; 2007 Feb; 16(4):410-23. PubMed ID: 17210673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts.
    Everts V; Hou WS; Rialland X; Tigchelaar W; Saftig P; Brömme D; Gelb BD; Beertsen W
    Calcif Tissue Int; 2003 Oct; 73(4):380-6. PubMed ID: 12874701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
    Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
    J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family.
    Motyckova G; Weilbaecher KN; Horstmann M; Rieman DJ; Fisher DZ; Fisher DE
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5798-803. PubMed ID: 11331755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cathepsin K in normal bone resorption.
    Troen BR
    Drug News Perspect; 2004; 17(1):19-28. PubMed ID: 14993931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin K and the design of inhibitors of cathepsin K.
    Yamashita DS; Dodds RA
    Curr Pharm Des; 2000 Jan; 6(1):1-24. PubMed ID: 10637370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Bone Resorption during Lactation in Pycnodysostosis.
    Jansen IDC; Papapoulos SE; Bravenboer N; de Vries TJ; Appelman-Dijkstra NM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.
    Schilling AF; Mülhausen C; Lehmann W; Santer R; Schinke T; Rueger JM; Amling M
    Osteoporos Int; 2007 May; 18(5):659-69. PubMed ID: 17206399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.
    Fratzl-Zelman N; Valenta A; Roschger P; Nader A; Gelb BD; Fratzl P; Klaushofer K
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1538-47. PubMed ID: 15070910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization.
    Gowen M; Lazner F; Dodds R; Kapadia R; Feild J; Tavaria M; Bertoncello I; Drake F; Zavarselk S; Tellis I; Hertzog P; Debouck C; Kola I
    J Bone Miner Res; 1999 Oct; 14(10):1654-63. PubMed ID: 10491212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.
    Wilson SR; Peters C; Saftig P; Brömme D
    J Biol Chem; 2009 Jan; 284(4):2584-92. PubMed ID: 19028686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
    Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
    J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
    Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
    J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsins in the osteoclast.
    Goto T; Yamaza T; Tanaka T
    J Electron Microsc (Tokyo); 2003; 52(6):551-8. PubMed ID: 14756243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.